Tocagen today announced it will report its third quarter 2017 financial results and business progress on Wednesday, November 8, 2017, after the close of the U.S. financial markets.
|
[01-November-2017] |
SAN DIEGO, Nov. 1, 2017 /PRNewswire/ -- Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced it will report its third quarter 2017 financial results and business progress on Wednesday, November 8, 2017, after the close of the U.S. financial markets. To receive Tocagen's press releases and other investor information, please visit the Investor Relations page of the company's website and register for email alerts. About Tocagen
View original content with multimedia:http://www.prnewswire.com/news-releases/tocagen-to-report-third-quarter-2017-financial-results-on-wednesday-november-8-300547678.html SOURCE Tocagen Inc. |
||
Company Codes: NASDAQ-NMS:TOCA |